FY2024 EPS Estimates for Prestige Consumer Healthcare Inc. (NYSE:PBH) Increased by Analyst

Prestige Consumer Healthcare Inc. (NYSE:PBHFree Report) – Analysts at William Blair increased their FY2024 earnings estimates for Prestige Consumer Healthcare in a research note issued on Thursday, February 8th. William Blair analyst J. Andersen now anticipates that the company will post earnings per share of $4.33 for the year, up from their prior forecast of $4.32. The consensus estimate for Prestige Consumer Healthcare’s current full-year earnings is $4.33 per share. William Blair also issued estimates for Prestige Consumer Healthcare’s Q4 2024 earnings at $1.14 EPS.

Prestige Consumer Healthcare (NYSE:PBHGet Free Report) last posted its quarterly earnings results on Thursday, February 8th. The company reported $1.06 EPS for the quarter, topping analysts’ consensus estimates of $1.04 by $0.02. The business had revenue of $282.74 million during the quarter, compared to analysts’ expectations of $280.25 million. Prestige Consumer Healthcare had a positive return on equity of 14.09% and a negative net margin of 7.11%. Prestige Consumer Healthcare’s quarterly revenue was up 2.6% on a year-over-year basis. During the same quarter last year, the company posted $1.04 earnings per share.

Several other equities analysts have also recently commented on PBH. BMO Capital Markets dropped their target price on shares of Prestige Consumer Healthcare from $124.00 to $117.00 and set an “outperform” rating for the company in a research report on Wednesday, November 15th. StockNews.com raised Prestige Consumer Healthcare from a “hold” rating to a “buy” rating in a research note on Saturday. Finally, Royal Bank of Canada lowered their price objective on shares of Prestige Consumer Healthcare from $110.00 to $103.00 and set a “sector perform” rating on the stock in a report on Wednesday, November 15th. One equities research analyst has rated the stock with a hold rating and three have assigned a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $97.00.

View Our Latest Stock Analysis on PBH

Prestige Consumer Healthcare Price Performance

Shares of NYSE PBH opened at $68.02 on Monday. The company has a current ratio of 3.09, a quick ratio of 1.92 and a debt-to-equity ratio of 0.75. The business’s 50 day moving average is $61.29 and its 200-day moving average is $60.24. Prestige Consumer Healthcare has a 1-year low of $55.96 and a 1-year high of $69.29. The firm has a market cap of $3.38 billion, a P/E ratio of -41.48, a price-to-earnings-growth ratio of 1.98 and a beta of 0.50.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of PBH. GAMMA Investing LLC bought a new stake in Prestige Consumer Healthcare during the 4th quarter worth approximately $25,000. Provence Wealth Management Group bought a new position in shares of Prestige Consumer Healthcare during the 3rd quarter valued at about $26,000. Pacer Advisors Inc. raised its holdings in shares of Prestige Consumer Healthcare by 85.7% during the 4th quarter. Pacer Advisors Inc. now owns 442 shares of the company’s stock valued at $27,000 after buying an additional 204 shares in the last quarter. Altshuler Shaham Ltd bought a new stake in Prestige Consumer Healthcare in the 4th quarter worth approximately $27,000. Finally, Principal Securities Inc. purchased a new stake in Prestige Consumer Healthcare in the fourth quarter worth approximately $29,000. 99.95% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, SVP Mary Beth Fritz sold 5,336 shares of the company’s stock in a transaction that occurred on Thursday, February 8th. The stock was sold at an average price of $69.00, for a total value of $368,184.00. Following the transaction, the senior vice president now owns 15,934 shares in the company, valued at $1,099,446. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. 1.60% of the stock is owned by insiders.

Prestige Consumer Healthcare Company Profile

(Get Free Report)

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.

Further Reading

Earnings History and Estimates for Prestige Consumer Healthcare (NYSE:PBH)

Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.